The G6PC1 gene helps the liver, kidneys, and intestine release glucose into the blood between meals, which supports steady energy levels. When this gene does not work properly, the body can struggle to maintain blood sugar during fasting, and sugar stores build up in the liver and kidneys instead of being released. This can cause glycogen storage disease type Ia, with features such as low blood sugar, an enlarged liver, slow growth, and changes in blood fats and uric acid. G6PC1 is mainly known in medical genetics rather than through public figures or popular culture.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when, where, and how much certain processes take place. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can read more in the LearnHub.
Overview
G6PC1Gene function
What if the gene works
The G6PC1 gene helps the liver, kidneys, and intestine release glucose into the blood. It supports the final step of making glucose from stored sugar and other fuels, especially between meals.
Risk
What if the gene does not work
More disruptive variants in the G6PC1 gene can cause glycogen storage disease type Ia. People may develop low blood sugar, an enlarged liver, poor growth, and changes in blood fats and uric acid, with severity and timing varying by variant.
Treatment
What does that mean for your treatment
Pathogenic or loss-of-function variants in the G6PC1 gene usually mean treatment centers on steady glucose support with frequent meals and uncooked cornstarch, including overnight planning. Fructose and galactose are often limited to reduce metabolic strain. No approved G6PC1-targeted drug is standard care; medicines are chosen mainly to manage complications such as high uric acid, high blood fats, or kidney strain.
Conditions associated with G6PC1
Gene function
What if the gene works
Between meals, your body needs a steady way to keep blood sugar in a healthy range. The G6PC1 gene makes a protein used mainly in the liver, kidneys, and small intestine to complete one of the last steps in releasing glucose into the bloodstream. This is part of how the body releases glucose between meals and overnight.
The G6PC1 gene helps cells make free glucose, the form of sugar that can be released into the blood. This supports a more steady blood sugar level between meals and during sleep.
In the liver and kidneys, its protein helps finish the process of turning stored sugar into glucose. This lets the body draw on energy reserves when food is not coming in.
Its protein also helps finish the process of making new glucose from other materials already in the body. This gives the bloodstream a steady supply of fuel during routine gaps between meals.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant may change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the G6PC1 gene can change the enzyme’s shape, stability, or working site, leaving it with less activity or none at all. The way G6PC1 gene variants affect enzyme function ranges from milder changes that keep some residual activity to more severe variants that nearly abolish it. In glycogen storage disease type Ia, people with two more disruptive variants often develop earlier and more pronounced features than those with variants that leave partial function.
How variants are linked to conditions
Pathogenic variants in the G6PC1 gene cause glycogen storage disease type Ia, also called von Gierke disease. The link between G6PC1 gene variants and glycogen storage disease type Ia is well established, and affected people can have low blood sugar, an enlarged liver, slow growth, and higher blood fats or uric acid. Over time, some may also develop kidney problems or liver adenomas, which are liver growths.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a part. In some cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For G6PC1, risk is mostly shaped by inheritance rather than lifestyle. A child develops the condition when both parents pass on a changed copy of the G6PC1 gene, so family history and having parents who are related by blood can raise the chance. Once someone has G6PC1-related disease, long fasting and illness can make problems more likely, but they do not change the underlying genetic cause.
Inheritance of G6PC1 variants
Variants in the G6PC1 gene are inherited in an autosomal recessive pattern, which is the usual G6PC1 inheritance pattern for glycogen storage disease type Ia. This means a child inherits one changed copy from each parent. If both parents carry a variant in the G6PC1 gene, each pregnancy has a 25% chance of the child having the condition, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Because the gene is on a non sex chromosome, this pattern is the same for boys and girls.
What does my G6PC1 result mean for my family?
G6PC1-related glycogen storage disease usually runs in families in a recessive pattern, so parents are often healthy carriers, and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change is present in their family, especially if there is a history of low blood sugar or liver problems in childhood. Children of someone with a G6PC1 result may be carriers, and their chance of being affected depends on the other parent’s gene result.
Genetic information
Genetic testing
How you find out about variants
G6PC1 genetic testing usually uses a blood or saliva sample to read the DNA code in the G6PC1 gene and look for variants. It can confirm whether a person carries two variants known to cause glycogen storage disease type Ia, and some labs also check for missing or extra pieces of the gene.
When should I consider getting a genetic test?
Consider testing the G6PC1 gene if someone has signs of a rare condition called glycogen storage disease type 1a, such as repeated low blood sugar between meals, a swollen belly from an enlarged liver, or poor growth. Testing also matters when this condition runs in the family or a relative has a known G6PC1 variant.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but what they reveal depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information gives context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results can help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug works well for one person, has less effect in another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, or moves a medication. These differences are common and can influence both how well a treatment works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences can affect a person’s response to medicines. It studies gene drug patterns to help explain why the same treatment may work differently in different people. With many medications, genes influence both how powerfully a drug works and how the body handles it. This understanding can support treatment choices that are better informed and more individualized. To look into this subject further, more information is available in the LearnHub.
Drugs influenced by the G6PC1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about medications, side effects, or your overall health are best discussed with your doctor.
History
The history of the G6PC1 gene is closely tied to the story of glycogen storage disease type I, first described by Edgar von Gierke in 1929. For decades, doctors could recognize the condition from its pattern in children, but the exact genetic cause was still unknown. Building on this early work, scientists linked the disease to a missing glucose 6 phosphatase activity in the mid 20th century. In the 1990s, researchers identified and mapped the G6PC1 gene, which allowed families to receive more precise genetic answers. That discovery helped confirm why some relatives shared the same condition across generations. Over time, descriptions became more precise as DNA testing replaced diagnosis based only on symptoms and liver biopsy findings.